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Objective: To determine mortality rates and to rank the causes and predictors of mortality 
using a wide range of sociodemographic and clinical variables. 
Materials and Methods: It is a prospective population-based cohort study of adults living in 
the community, 2013-15 (N = 48,691, age ≥50; deceased = 1,944). Clinical and 
sociodemographic data were obtained from the Survey of Health, Ageing and Retirement in 
Europe (SHARE): Age, Gender, Marital Status, Years of Schooling, Income, Loneliness, 
Cognition, Self-Rated Health, Diseases, Activities of daily living (ADL), and Frailty. Mortality 
rates were calculated. A Cox proportional hazards model were used to determine risk-
adjusted mortality ratios. 
Results: The crude mortality rate was 18.39 (1000 person-years at risk), (99% CI, 18.37-
18.42). The factors most associated with an increased mortality risk were older age, lower 
self-rated health, lower cognition, male gender, ADL deficits, higher comorbidity, frailty and 
loneliness. The diseases with a higher mortality risk were: cancer (Hazard ratio, HR = 2.67), 
dementia (HR = 2.19), depressive symptoms (HR = 2.10), fractures (hip, femur) (HR = 1.57), 
stroke (HR = 1.55), chronic lung disease (HR = 1.52), diabetes (HR = 1.36) and heart attack 
(HR = 1.21). 
Conclusions: The main mortality risk factors, associated independently in the eight diseases 
were: older age, poor self-rated health, ADL deficits, male gender, lower cognition, 
comorbidity and the presence of depressive symptoms, with a different influence in the 
European regions. The need to evaluate and treat the depressive symptoms that 
accompanies diseases with higher risk of mortality is stressed. 





People aged over 65 years in Europe represented 19.4% of the population in 2016 and 
this number is forecast to grow continuously until 2050 (European Comission, 2017). This 
aging population presents new challenges related to chronic diseases and their associated 
functional and cognitive consequences. It is essential to identify the causes of mortality and 
its associated risk factors and to design preventive measures to be able to improve quality of 
life among the elderly. 
 Data from Eurostat (2014a), showed that the gross mortality rate (per 1,000 inhabitants) 
of people aged over 50 years in the EU-28 was 18.10, although distribution by age brackets 
showed large differences: 3.81 at 50-64 years, 21.36 at 65-79 years and 100.21 at ≥ 80 years. 
In another Eurostat report (2014b), the main causes of death (per 1,000 inhabitants) in 
people aged over 65 years in Europe were ranked as follows: circulatory system diseases 
category 17.27, cancer 10.54, cerebrovascular diseases 4.02, respiratory system diseases 
3.65, mental illnesses 1.82, and external causes 1.25. Several community studies have 
identified older age and, to a lesser degree, male gender as mortality risk factors (Zhang et 
al., 2012; Huang et al., 2017). 
An increase in the risk of mortality has been related to the presence of depressive 
symptoms (Vilalta-Franch et al., 2012; Teng, Yeh, Lee, Lin, & Lai, 2013; Péquignot et al., 
2019), associated with disability (Murphy et al., 2016), or cognitive deficits (Georgakis et al., 
2016). Living alone or having feelings of loneliness were independent factors associated with 
increased mortality (Tabue Teguo et al., 2016). Cognitive impairment has also been 
associated with increased risk of mortality in general (Park, Lee, Suh, Kim, & Cho, 2014; Hu et 
al., 2019), and in various chronic diseases (Batty, Deary, & Zaninotto, 2016). 
Self-rated health was found to be an independent predictor of mortality (Falk et al., 2017; 
Szybalska et al., 2018), and showed a similar predictive power when objective health 
measures were used (Lima-Costa, Cesar, Chor, & Proietti, 2012). Greater frailty (Garre-Olmo, 
Calvó-Perxas, López-Pousa, de Gracia Blanco, & Vilalta-Franch, 2013; Ravindrarajah et al., 
2013), and deficits in Activities of Daily Living (ADL) were associated with higher mortality 
risk (Formiga et al., 2016; Nascimento, Oliveira, Firmo, Lima-Costa, & Peixoto, 2018). Finally, 




Thumé, & Facchini, 2016) and the accumulation of geriatric syndromes (Huang et al., 2017) 
were relevant risk factors. 
While certain studies analysed some of the risk factors in isolation, the aim of the present 
study was to determine mortality rates and the main risk factors, using a wide range of 
sociodemographic and clinical variables from a large population sample of people aged over 
50 years in Europe (2013-15), exploring the differences in four European regions. 
 
2. Materials and Methods  
2.1. Design and Participants  
The study is a prospective population cohort study including data from the waves 5 and 6 
of the "Survey of Health, Aging and Retirement in Europe" (SHARE), corresponding to the 
years 2013 and 2015. People aged over 50 years with complete data in both waves were 
included, in addition to people who died between 2013 and 2015 (Malter, & Börsch-Supan, 
2015, 2017).The study was approved by the Ethics Committee of the Institute of Biomedical 
Research of Girona Dr Josep Trueta. 
Participants were selected from countries with longitudinal data for Waves 5 and 6: 
Denmark, Sweden, Switzerland, Luxemburg, Austria, Germany, Belgium, France, Slovenia, 
Czechia, Estonia, Spain, Italy and Israel. Response rates in the countries varied from 57.9% in 
France, to 85.0% in Estonia (Malter, & Börsch-Supan, 2015, 2017). The final study sample 
consisted of 48,691 subjects, with complete data on both waves 5 and 6, among which 1,944 
died between the two waves.  
Mortality data were registered using a standardized interview that collects information 
on the cause and on several circumstances of the death. 
2.2. Measures  
The variables and instruments used from the SHARE interview for the present study were 
the following: 
2.2.1. Sociodemographic data: Age (50-64 / 65-79 / ≥80 years), Gender (male/female), 




Economic household income in percentiles (100-70 / 60-10 ), Ever smoked daily (yes / no) 
and Physical exercise (no / yes).  
2.2.2. Loneliness: Was measured using a short scale of Loneliness (Hughes, Waite, 
Hawkley, & Cacioppo, 2004), consisting of three items (lack of companionship, feeling left 
out, feeling isolated) and with a score range of 3 to 9. Cronbach's alpha in the original scale 
was 0.72. Scores above 3 were regarded as reflecting feelings of loneliness. 
2.2.3. Depressive symptoms. The scale used was the EURO-D (Prince et al., 1999), 
consisting of 12 items (depressive symptoms, pessimism, death wish, guilt, irritability, crying, 
fatigue, sleep problems, loss of interest and appetite, reduced ability to concentrate and 
capacity to enjoy things over the last month). Answers were dichotomous with a range of 0-
12 points. The cut-off point for clinically significant depressive symptoms was ≥4, with a 
mean sensitivity of 74.8% and a mean specificity of 82% among different European 
countries. Cronbach's alpha showed moderate values (0.69). 
2.2.4. Physical Health. It was assessed using the following variables: Self rated health 
(Excellent/Very good - Good – Fair/Poor), Self-referred presence of diseases (heart attack, 
hypertension, cholesterol, stroke, diabetes, chronic lung, cancer, ulcer, Parkinson’s disease, 
fractures: hip-femur, other fractures, dementia, cataracts, rheumatoid arthritis, other 
emotional disorders, other diseases) and presence of Deficits in Activities of Daily Living (ADL 
- six basic and seven instrumental activities). 
2.2.5. Cognition. The following measurements were used to assess participants’ cognitive 
status: immediate recall (score range = 0-10), delayed recall (score range = 0-10), numeric 
ability to subtract (score range = 0-5), and verbal fluency (score range = 1-10). A global 
cognitive score was calculated as the sum of all these scores, and it had a range from 0 to 35. 
This variable was further stratified into three equivalent groups in terms of number of 
participants (>18 / 14-17 / <14). 
2.2.6. Frailty. It was measured using the following four items of the SHARE interview: 
falling, fear of falling down, dizziness, and fatigue. It was categorized as presence / absence. 
2.3. Statistical analysis  
A bivariate analysis of the variable frequencies was performed to examine the differences 
between survivors and deceased using the chi square test (χ2). To assess the magnitude of 




variables (weak <0.50, moderate 0.50-0.80, strong> 0.80) and Cramer's V (V), for categorical 
variables (df1 = small: ≤0.10, medium: 0.11-0.49, large: ≥0.50; df2 = small: ≤0.07, medium: 
0.08-0.34, large: ≥0.35; df3 = small: ≤0.06, medium: 0.07-0.28, large: ≥0.29) (Cohen, 1988). 
Crude mortality rates were calculated for each variable and disease: number of deaths 
divided by the total number of years at risk x 1000. Confidence intervals (99.9% CI) were 
based on Poisson exact distribution. The standardized rate was calculated based on the 
direct method (Schoenbach, & Rosamond, 2000), taking the analysed age groups into 
account. 
Cox multivariate regression analyses were performed using clinical and sociodemographic 
factors and diseases to determine the hazard ratio of each variable and the confidence 
intervals (99.9% CI). The effect size of the Hazard ratio (HR) was evaluated as small (<1.22), 
medium (1.23-2.99) and large (> 3.00) (Olivier, May, & Bell, 2017). Kaplan-Meier survival 
curves and log-rank tests were used for the most relevant variables. 
To identify the variables associated with deaths in European regions, countries were 
grouped into four regions according to social welfare models (Whelan and Maître, 2010): 
Northern (Denmark, Sweden), Continental (Switzerland, Luxembourg, Austria, Germany, 
Belgium, France), Eastern (Slovenia, Czech Republic, Estonia) and Southern (Spain, Italy, 
Israel). 
Calibrated longitudinal individual weights provided by SHARE (Malter, & Börsch-Supan, 
2015) were used for the bivariate analysis and mortality rate calculation. The level of 
statistical significance used was <0.05 and 99.0% confidence intervals. Statistical analysis was 
performed using SPSS v24.0 for Windows (IBM SPSS Corp., Amonk, NY), and STATA v15.1 
(StataCorp LLC, College Station, Texas). 
 
3. Results 
3.1. Differences between valid and missing participants 
The initial Wave 5 sample included 60,919 participants, of which 12,228 were lost to 
follow-up. Thus, the final sample consisted of 48,691 (46,747 survivors and 1,944 deceased 
over Waves 5 and 6). Lost cases showed only minimal differences with the individuals in the 




(54.0% vs 55.7 %, P < 0.001, V = 0.01), lower cognitive function (15.4 vs 15.7, P < 0.001, d = 
0.07), lower number of diseases (2.01 vs 2.09, P < 0.001, d = 0.04), and somewhat greater 
depressive symptoms (2.53 vs 2.46, P = 0.003, d = 0.03). 
3.2. Differences between survivors and deceased 
In the bivariate analysis (Table 1), the most relevant differences between survivors and 
deceased were that the latter were older (V = 0.23), had more ADL deficits (V = 0.22), a 
worsened self-rated health (V = 0.16), a lower cognitive function (V = 0.16), no practice of 
physical exercise (V= 0.14), more physical diseases (V = 0.13) and with the presence of 
depressive symptoms (V = 0.13). Deceased participants also showed greater frailty 
difficulties with moderate differences (V = 0.12). In the four European regions there were 
higher death rates in the Eastern and Southern regions (V = 0.07). 
Finally, widowers (V = 0.11), and those with lower schooling (V = 0.10) were also 
associated with a greater number of deaths, although in smaller proportions. Loneliness, 
lower income, gender and ever smoked daily, were seen to have a weak effect on mortality. 
3.3. Mortality rates  
The crude death rate (per 1000 hab.) was 18.39 (99.0% CI, 18.37-18.42) people-years at 
risk for the whole sample. Some categories had higher than average mortality rates across all 
factors, which became more relevant with age, ≥80 years (rate, r = 72.04) and with ADL 
deficits (r = 61.47). Lower cognitive function (r = 41.11), widowers (40.88), fair/poor self-
rated health (r = 36.91), less schooling (r = 36.25), frailty (r = 34.05), no physical exercise (r = 
33.21), loneliness (r = 28.83), lower income (r = 23.61), ever smoked daily (r = 21.79) and 
men (r = 19.53), also had higher than average rates. Regarding the European regions, the 
Eastern (r = 26.58) and Southern (r = 27.41) regions had the highest mortality rates.  
All diseases had higher than average mortality rates, with highest rates detected in 
dementia (r = 166.57), Parkinson’s disease (r = 87.13), fractures (hip/femur) (r = 72.14), 
stroke (r = 65.73), cancer (r = 61.13), chronic lung disease (r = 47.68), heart attack (r = 45.30), 
depressive symptoms (r = 41.58), cataracts (r = 40.29) and diabetes (r = 66.18). (See 





3.4. Factors associated with an increased risk of mortality 
In the Cox multivariate regression, the most relevant factor associated with the deceased 
cases was age (HR = 5.16 to 2.23). A second group of factors (HR = 2.11 to 1.31) included: 
lower self-rated health, ADL deficits, male gender, lower cognitive function, no physical 
exercise, comorbidity and ever smoking daily . A third group with lower HR (HR = 1.20 to 
1.19) included widowhood, loneliness and depression. Economic income and fragility did not 
present significant risks in the global sample, except in some European regions. Area location 
and education did not show any significant risk increase (Table 2). 
Some differences were observed between the European regions associated with a higher 
risk. Compared to the mean risk of all cases, the Nordic region had a higher risk with the 
older age (HR = 9.89 vs. HR = 5.16) and with the lowest income (HR = 1.72 vs. HR = 1.03). 
Among the deceased cases with lower income (≤ 60 perc.), the highest percentages 
corresponded to Sweden (90.4%) and Denmark (95.2%), above the percentage 
corresponding to all the cases (82.3%). 
In the Continental region, a greater risk with comorbidity (HR = 2.18 vs. H = 1.72) and with 
ADL deficits (HR = 2.30 vs. HR = 1.90) was seen, while in the Eastern region, there was a 
lower relevance of self-perceived health (HR = 1.15 vs. HR = 2.11) and a greater fragility (H = 
1.40 vs. HR = 1.12). In the Southern region, older age (HR = 6.05 vs. HR = 5.16), worse health 
self-perception (HR = 2.56 vs. HR = 2.11), widowhood (HR = 1.34 vs. HR = 1.20), loneliness 
(HR = 1.33 vs. HR = 1.19) and depression (HR = 1.29 vs. HR = 1.19) were the most relevant 
differences (Table 2). 
Supplementary Table 2 shows the proportions of deaths, and crude and adjusted risks, in 
each of the 14 countries, grouped by region. 
3.5. Diseases associated with an increased mortality 
In the Cox multivariate regression, participants with cancer, dementia, depressive 
symptoms, fractures (hip/femur), stroke, chronic lung disease, diabetes and heart attack, 
had an increased risk of death (HR = 2.67 to 1.21). Participants having more than two of 
these eight diseases (>2 comorbidity, rate = 104.81) had the highest mortality risk.  
Parkinson disease, other diseases, other fractures, other emotional disorders, rheumatoid 




Cholesterol (HR = 0.77) and Osteoarthritis (HR = 0.88), however, seemed to be protective 
factors (Table 3).    
Supplementary Table 3 shows the frequency of survivors and deceased for each disease 
and the mean age of death. 
3.6. Factors and comorbidity associated with increased mortality 
The factors associated in the Cox regression (adjusted for countries), with the eight 
diseases as a whole with the highest risk of mortality (cancer, dementia, depression, 
fractures-hip/femur, stroke, chronic lung disease, diabetes and heart attack), were: age (65-
79 years, HR = 2.07, 99.0%CI = 1.63-2.64; ≥ 80 years, HR = 4.80, 99.0%CI = 3.76-6.14), self-
rated health (good, HR = 1.55, 99.0%CI = 0.94-2.57; fair-poor, HR = 2.41, 99.0%CI = 1.48-
3.92), ADL deficits (HR = 2.06, 99.0%CI = 1.74-2.45), no physical exercise (HR = 1.99, 99.0%CI 
= 1.62-2.44), male gender (HR = 1.81, 99.0%CI = 1.56-2.11), comorbidity (>2, HR = 1.68, 
99.0%CI = 1.44-1.95), cognition (<14, HR = 1.63, 99.0%CI = 1.24-2.15), loneliness (HR = 1.23, 
99.0%CI = 1.06-1.42), ever smoked daily (HR = 1.21, 99.0%CI = 1.04-1.41) and frailty (HR = 
1.12, 99.0%CI = 0.94-1.33). 
The Hazard ratios (adjusted for country, gender and age) of the eight diseases as a whole 
were: cancer (HR = 2.47, 99.0%CI = 2.09-2.92), dementia (HR = 2.24, 99.0%CI = 1.85-2.71), 
depressive symptoms (HR = 1.93, 99.0%CI = 1.66-2.24), fractures (HR = 1.52, 99.0%CI = 1.19-
1.93), stroke (HR = 1.48, 99.0%CI = 1.23-1.78), chronic lung disease (HR = 1.44, 99.0%CI = 
1.21-1.71), diabetes (HR = 1.23, 99.0%CI = 1.06-1.43), and heart attack (HR = 1.13, 99.0%CI = 
0.97-1.30). 
Table 4 shows the risk factors associated with each of the diseases that have the highest 
risk of mortality. Comorbidity and depression were associated with an increased risk for 
each of the 8 diseases.  
Figure 1 shows the survival curves of Kaplan-Meier with the mortality trajectories for 
each of the diseases with greater risk, as well as for comorbidity. By analysing the diseases 
independently, the order of highest to lowest risk (HR) was modified: dementia (HR = 9.26, 
99.0%CI = 7.79-11.02), fractures (hip or femoral) (HR = 3.71, 99.0%CI = 2.93-4.70), stroke (HR 
= 3.54, 99.0%CI = 2.98-4.22), cancer(HR = 3.38, 99.0%CI = 2.88-3.96), depressive symptoms 




disease (HR = 2.54, 99.0%CI = 2.14-3.00), diabetes (HR = 1.98, 99.0%CI = 1.73-2.28) and 
comorbidity (HR = 6.13, 99.0%CI = 5.35-7.04) 
 
4. Discussion 
4.1. Mortality rates and predictive factors 
The main objective of this study was to determine the mortality rate in Europeans aged 
50 years and over, and to quantify the effect of several sociodemographic and clinical 
variables, using data from a large representative cohort of the European population. 
The estimated mortality rate in people aged 50 and over in our study was 18.39, which is 
in line with the crude rate for 28 European countries (18.10) and the standardized rate 
(18.47), calculated using Eurostat data (2014a) for 15 countries (Supplementary Table 4). 
In addition to older age, the most relevant predictors of mortality in our study were, in 
order of importance: lower self-rated health, ADL deficits, male gender, no physical exercise, 
lower cognitive function, higher comorbidity and ever smoking daily. These predictors were 
in agreed with previous research. The lower self-rated health factor is interesting: though it 
is a simple measure, several authors have indicated that it is a strong predictor of mortality 
risk (Lima-Costa et al., 2012; Falk et al., 2017; Szybalska et al., 2018). ADL deficits (Formiga et 
al., 2016; Nascimento et al., 2018), and lower cognitive function (Park et al., 2014; Batty et 
al., 2016; Hu et al., 2019) have also been considered as a relevant mortality factor. Also, the 
presence of feelings of loneliness or living alone were associated a higher risk (Tabue Teguo 
et al., 2016). Comorbidity, as a risk factor, was widely present in most studies (Gagne et al., 
2011; Nunes et al., 2016), associated with ADL deficits (Formiga et al., 2016) and the 
accumulation of geriatric syndromes (Huang et al., 2017).  
Finally, the practice of physical exercise was associated with lower mortality 
(Georgiopoulou et al., 2017; Pedisic et al., 2020) and, on the contrary, smoking regularly was 
associated with higher mortality (Nash, Liao, Harris, & Freedman, 2017).  
The aspects related to health (Self-Rated Health, ADL deficits and Comorbidity), were 
highly related to mortality according to our study. The greater presence of diseases in older 
people is associated with greater ADL deficits and, regarding self-perceived health, they 
themselves are aware of their health deficits. Self-reported health deficits are therefore as 




4.2. Diseases presenting a higher risk of mortality 
Our results identify eight diseases that had the highest mortality rates, most of which are 
included within the WHO’s top ten causes of death (WHO, 2016). Nevertheless, depression 
and hip/femur fractures are not included in this list but had also higher than average 
mortality rates in our study. 
Depression has been previously linked to increased mortality (Cuijpers et al., 2014) and it 
has been reported that this association has a long-term effect (Gilman et al., 2017). The 
effect of depression on excess mortality has been related to an increased suicide risk, but 
also to many major medical causes, which is in line with our results where depression is 
comorbid with many other diseases (Zivin et al., 2015). It should also be borne in mind that 
depression and loneliness combined in older people constitute an important predictor of 
mortality (Holwerda et al., 2016).  
Our results also highlighted hip/femur fractures as a risk for mortality, which has been 
widely studied in the recent years. Thus, these fractures have been described to have short- 
and long-term effect increasing mortality, and that this risk is increased regardless of the 
gender (von Friesendorff et al., 2016; Katsoulis et al., 2017). 
According to our results, some factors amplified the risk when associated with the eight 
diseases we found to be related to excess mortality: other comorbidities (i.e. concomitant 
diabetes, or hypertension, among others), deficits in ADL performance, worsened self-rated 
health, and as previously discussed, depression. 
Increased comorbidity has been identified as a general risk factor for mortality (Nunes et 
al., 2016) and specifically in cancer (Ferrat et al., 2015), dementia (Zekry et al., 2011; Todd, 
Barr, Roberts, & Passmore, 2013) or some fractures (Chang et al., 2018). In the same line, 
pulmonary diseases were seen to present a higher risk in patients with heart failure 
(Matsushita, Sakata, Satoh, & Yoshino, 2019), and heart disease had an increased risk with 
cholesterol (Liao, Zeng, Zhao, Guo, & Zhang, 2017). Moreover, diabetes was associated with 
higher mortality in patients with stroke, cholesterol (Araki et al., 2012), and pulmonary 
diseases (Ho et al., 2017). A relevant aspect of comorbidity is the inverse relationship 
between cancer and dementia; older people with cancer have a reduced risk of dementia 




Functional deficits in ADL were also previously associated with greater mortality in 
dementia (Zekry et al., 2011; Todd et al., 2013), depressive symptoms (Murphy et al., 2016), 
and with Parkinson’s disease (Santos-García et al., 2018). Regarding poorer self-rated health, 
it has been reported to predict mortality in cancer (Giltay, Vollaard, & Kromhout, 2012), 
depression (Falk et al., 2017), lung diseases and stroke (Fernández-Ruiz et al., 2013) and 
heart failure (Johansson, Broström, Dahlström, & Alehagen, 2008).  
As previously discussed, our results highlight depression as a risk factor for increased 
mortality, both by itself, and when it appears comorbid with other diseases such as 
dementia, chronic lung disease, hip/femur fracture, heart attack, cancer, stroke, diabetes 
and Parkinson’s disease. Some authors have questioned whether depression constitutes an 
independent mortality factor and have emphasized that the severity of one’s physical health 
condition is a determinant of mortality (Batterham, Christensen, & Mackinnon, 2012; 
Benabarre et al., 2014). However, our own results and those of many other authors, show 
that depression is a risk factor for mortality in general (Teng et al., 2013; Murphy et al., 
2016; Péquignot et al., 2019) and acts as a booster of this risk when it appears comorbid 
with cancer (Parpa, Tsilika, Gennimata, & Mystakidou, 2015), dementia (Lara, Haro, Tang, 
Manly, & Stern, 2016), stroke (Krivoy et al., 2017), heart failure (Gathright, Goldstein, 
Josephson, & Hughes, 2017), diabetes (Limongi, Noale, Crepaldi, & Maggi, 2014), and 
Parkinson’s disease (Shoval et al., 2017). 
Despite the importance of mortality data, several studies show the ability to reduce risk 
factors and mortality rates. Thus, the application of the recommendations of the medical 
guidelines for prevention of cancer and cardiovascular diseases have reduced mortality rates 
(Greenlee et al., 2017), programs to reduce mortality in patients with hip fracture (Mahran et 
al., 2019) or programs to prevent falls in older people, related to increased mortality (Pahor, 
2019; Liu-Ambrose et al., 2019), are some examples. Specifically, the programs of evaluation 
and prevention of health in geriatrics have shown their effectiveness by reducing mortality by 
20% in people over 70 years, with a mean follow-up of 6.2 years (Frese, Deutsch, Keyser, & 
Sandholzer, 2012). 
4.3. European regions, mortality and public health services 
Data from our study indicate higher mortality rates in Eastern European countries. The 




through optimal quality medical care. With respect to the European average (rate = 127, 
standardized rates by age per 100,000 inhabitants), Eastern European countries had higher 
avoidable mortality rates, especially the Czech Republic (r = 179) and Estonia (r = 224) that 
could be lowered through an improvement of the public health system. 
A recent article (Anderson, Wilkinson, & Schafer, 2019) related the quality of medical 
care, measured with the Objective quality of the health system (HAQ Amenable Mortality 
Index; Barber et al., 2017), with the reduction of the disease and disability in older age. 
Continental countries such as Belgium, France, Germany, Switzerland, Spain or Sweden had 
a higher HAQ index, while countries such as the Czech Republic, Slovenia, Israel and 
Denmark had a lower HAQ. In our study, the adjusted mortality risk confirms that 
continental countries have a lower mortality risk, while the Czech Republic and Denmark 
have a higher risk (see Supplementary Table 2). 
Undoubtedly, the public resources dedicated to the health system, in terms of Gross 
Domestic Product (GPD), of the year 2015 (OECD / EU, 2016) are relevant for its 
improvement. The Eastern European countries have an investment less than the mean of 
Europe, although this could also apply to the countries of Southern Europe. Some authors 
have already pointed out that the decrease in public spending on health is associated with 
an increase in mortality in the short and long term (Budhdeo et al., 2015). 
Regarding the surprising fact of the higher risk of mortality with low incomes in the 
Nordic countries, Mackenbach (2017) analyses the paradoxes that occur in the European 
context. Socio-economic inequalities in mortality and morbidity also occur in countries with 
broad welfare policies, such as in the Nordic countries, while they are lower in southern 
European countries with their more family-based welfare models. The author argues that in 
the Nordic countries there would be people with a higher educational level ⋍ higher income, 
those who better implemented prevention interventions, in contrast to those with a lower 
educational level ⋍ lower income. In the countries of southern Europe, economic, social and 
cultural modernization, which occurred later, would preserve traditional values, with the 
family as a source of social protection to mitigate inequalities. In Eastern European 
countries, inequality in mortality would be related to the difficulties of political transition: 
poverty, excessive consumption of alcohol and tobacco and collapse of social protection and 




4.4. Limitations  
The study has certain limitations that should be mentioned. First, all the diseases were 
reported by the participants through a question asking if a doctor ever diagnosed them with 
these diseases, and no medical record was obtained. Second, all the information was obtained 
from a population survey and the lack of clinical data difficult to specifically analyse the 
variables that may influence the diseases. Third, there is no information on the cases lost in 
Wave 6 (12,228; 20.1% of the total), although the differences with the follow-up cases were 
minimal and the mortality rates were consistent with Eurostat’s epidemiological data. Fourth, 
pharmaceuticals used by the participants to treat the diseases analysed in this study were not 
considered, and this may be a source of variability we did not control for. Fifth, comment that 
the study assesses the risk of short-term mortality, with only two years of follow-up. Finally, 
despite analysing the predictors for the four European regions, the country-specific predictors 
could not be analysed due to lack of space, a pending issue for future research. 
 
5. Conclusions 
The overall mortality rates in people older than 50 years were: crude, 18.39 and 
standardized, 18.47 (per 1,000 persons-year at risk). The most relevant factors associated 
with excess mortality were, in the following order: older age, lower self-rated health, ADL 
deficits, male gender, lower cognitive function, lack of physical exercise, higher comorbidity, 
smoke, loneliness and depression.  
Diseases presenting the highest mortality risk were cancer, dementia, depressive 
symptoms, lung diseases, stroke, fractures, heart attacks and diabetes. When these diseases 
occurred together with older age, comorbidities, depressive symptoms, ADL deficits and lower 
self-rated health, the risk of mortality increased.  
Identifying the risk factors in these eight diseases with a relevant comorbidity rate, the 
implementation of medical prevention guidelines, and treating potentially modifiable diseases 
– such as loneliness, cholesterol, hypertension, diabetes and depressive symptoms in 
particular – may make it possible to reduce the mortality risk.  
The improvement of public health services would undoubtedly allow the prevention and 




deficits. However, the lower mortality would not only be related to an improvement of the 
health system or greater economic investment, but also to other relevant factors, such as the 
implementation of formal and informal support systems, inequalities in education, lifestyle , 
diet, poverty and toxic habits. Health systems and social protection for the elderly, especially 
in situations of loneliness and depression, would require more specific attention to this group. 
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Table 1   
Sociodemographic and clinical factors in Wave 5. Differences between survivors and deaths  
  Survivors Deaths Survivors Deaths 
 N 46747 1944 (4%) 46747 1944 (4%)
Age, years 
 mean (SD) 66.3 (10.5) 78.8 (10.5) 
 t, P, d < 0.001, 1.19 
Groups (%)    
 50-64 99.2 0.8 
 65-79 96.6 3.4 
 ≥ 80 86.5 13.5 
 χ2 (df = 2), P, V < 0.001, 0.23  
 
Gender (%)  
 Male 96.6 3.4  
 Female 96.2 3.8  
 χ2 (df = 1), P, V < 0.001, 0.01   
 
Marital status (%) 
 Married 97.3 2.7  
 Single /Divorced 97.5 2.5
   
 Widowed 92.1 7.9  
 χ2 (df = 2), P, V < 0.001, 0.11  
 
Schooling, years (%)  
 >12  98.2  1.8 
 12-8  96.7  3.3 
 <8  93.0  7.0 
 χ2 (df = 2), P, V < 0.001, 0.10  
 
Income, percent. (%) 
 70-100 97.6  2.4  
 10-60 95.0  5.0 
 χ2 (df = 1), P, V < 0.001, 0.07 
 
Loneliness (%)  
 No 97.8  2.2 
 Yes 94.4  5.6 
 χ2 (df = 1), P, V  < 0.001, 0.09 
 
Ever smoked daily 
 No 96.2  3.8 
 Yes  95.8  4.2 
 χ2 (df = 1), P, V < 0.001, 0.01 
 
Physical exercise  
 Yes  98.9  1.1 
 No  93.6  6.4 
 χ2 (df = 1), P, V < 0.001, 0.14 
Cognition (%)  
 >18 99.2 0.8  
 18-14 97.9 2.1 
 <14 92.1 7.9 
 χ2 (df = 2), P, V  < 0.001, 0.16 
 
Self-R Health (%) 
 Excel. / Very good 99.3 0.7 
 Good 98.3 1.7 
 Fair / Poor 92.8 7.2 
 χ2 (df = 2), P, V < 0.001, 0.16  
 
Diseases (18) (%) 
 0-1 98.7 1.3 
 2-3 96.6 3.4 
 > 3 91.1 8.9  
 χ2 (df = 2), P, V < 0.001, 0.15 
 
ADL deficits (%) 
 No 98.5 1.5 
 ≥ 1 88.4 11.6 
 χ2 (df = 1), P, V < 0.001, 0.22   
 
Frailty (%) 
 No 98.1 1.9  
 ≥ 1 93.4 6.6 
 χ2 (df = 1), P, V < 0.001, 0.12 
 
EURO-D (%) 
 <4 97.9 2.1  
 ≥4  92.7 7.3  
 χ2 (df = 1), P, V  < 0.001, 0.13 
 
European regions  
 Continental 97.5 2.5 
 Nordic 96.8 3.2  
 Eastern 94.9 5.1 
 Mediterranean 94.9 5.1 
 χ2 (df = 3), P, V < 0.001, 0.07 
 
Weighted data. ADL, Activities of daily living; EURO-D, Depression scale; df, degrees of freedom; V, Cramer’s; d, 
Cohen’s d; t, Student t test; χ2, Chi-Square test. Effect size, for Cohen’s d (weak< 0.50), moderate 0.50-0.80), strong > 
0.80). Effect size for Cramer’s V (df1 = small: ≤0.10, medium: 0.11-0.49, large: ≥0.50; df2 = small: ≤0.07, medium: 0.08-
0.34, large: ≥0.35; df3 = small: ≤0.06, medium: 0.07-0.28, large: ≥0.29). Effect size medium and large, in bold.  
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Table 2   
Cox regression. Multivariate analysis of factors in Wave 5, for countries. Cases of death from wave 6  
 All cases† Nordic  Continental  Eastern Southern  
 Groups  HR 99.0% CI HR 99.0% CI HR 99.0% CI HR 99.0% CI HR 99.0% CI 
Age groups  R: 50-64  
  65-79 2.23 1.81-2.73*** 4.42 1.88-10.4*** 2.21 1.51-3.24*** 1.81 1.31-2.51*** 2.45 1.61-3.73*** 
  ≥80 5.16 4.13-6.44*** 9.89 4.02-24.3*** 4.92 3.23-7.50*** 4.10 2.86-5.88*** 6.05 3.88-9.43*** 
 
Self-Health  R: Exc./V. good  
 Good 1.29 0.96-1.72* 1.31 0.70-2.45 1.24 0.74-2.09 0.77 0.42-1.42 1.47 0.79-2.73 
 Fair / Poor 2.11 1.58-2.81*** 2.01 1.10-3.69** 1.83 1.08-3.11** 1.15 0.64-2.07 2.56 1.40-4.66*** 
 
ADL deficits  ≥1 1.90 1.64-2.21*** 2.16 1.40-3.33*** 2.30 1.70-3.13*** 1.48 1.14-1.91*** 2.15 1.63-2.85*** 
 
Gender  male 1.90 1.65-2.19*** 1.94 1.31-2.86*** 1.64 1.24-2.17*** 2.03 1.58-2.61*** 2.04 1.57-2.65*** 
 
Cognition  R: >18  
 14-18 1.27 1.00-1.61* 0.95 0.50-1.81 1.11 0.73-1.67 1.29 0.88-1.89 1.73 0.79-3.83 
 <14 1.88 1.48-2.40*** 1.94 1.03-3.64** 1.73 1.14-2.62** 2.07 1.42-3.03*** 1.78 0.81-3.90 
 
Physical exercise No 1.85 1.57-2.18*** 1.85 1.16-2.96** 2.09 1.49-2.92*** 1.96 1.49-2.56*** 1.67 1.20-2.34*** 
 
Comorbidity  >2 1.72 1.47-2.01*** 1.88 1.14-3.09** 2.18 1.59-2.98*** 1.69 1.28-2.24*** 1.44 1.10-1.87*** 
 
Ever smoking daily Yes 1.31 1.15-1.50*** 1.30 0.89-1.91 1.42 1.09-1.85** 1.33 1.05-1.68** 1.16 0.90-1.49 
 
Marital status R: Married  
 widowed 1.20 1.03-1.41** 1.37 0.88-2.14 1.10 0.81-1.50 1.14 0.87-1.50 1.34 1.02-1.75** 
 
Loneliness Yes 1.19 1.04-1.37** 1.06 0.71-1.58 1.04 0.80-1.35 1.18 0.93-1.48 1.33 1.04-1.69** 
 
Depression ≥ 4 EURO-D 1.19 1.03-1.38** 1.14 0.74-1.75 1.20 0.89-1.60 1.09 0.85-1.40 1.29 0.97-1.71* 
 
Frailty ≥1 1.12 0.96-1.30 1.08 0.69-1.69 1.07 0.79-1.45 1.40 1.07-1.82** 0.98 0.76-1.27 
Income (percent.) <60 1.03 0.89-1.20 1.72 0.87-3.41* 1.15 0.85-1.56 1.04 0.80-1.34 0.89 0.69-1.14 
 
 
Unweighted data; † Adjusted for country; †Method: Forward Wald; R, Reference group; HR, Hazard ratio; CI, Confidence interval; ADL, Activities of daily living; EURO-D, 
Depression scale. Time = Years at risk. Event = Death. *P < 0.05, **P < 0.010, ***P < 0.001.
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Table 3   
Cox regression. Multivariate analysis of diseases in wave 5. Cases of death from wave 6 
 B  (SE) HR 99.0% CI P-value 
Cancer   0.981 (0.063) 2.67 2.26-3.14 < 0.001  
Dementia  0.785 (0.075) 2.19 1.81-2.66 < 0.001 
Depressive Symptoms 0.745 (0.051) 2.10 1.84-2.40 < 0.001 
Fractures (hip/femur) 0.451 (0.095) 1.57 1.23-2.00 < 0.001 
Stroke   0.440 (0.071) 1.55 1.29-1.86 < 0.001 
Chronic Lung   0.419 (0.068) 1.52 1.28-1.81 < 0.001 
Diabetes   0.308 (0.057) 1.36 1.17-1.57 < 0.001 
Heart Attack   0.188 (0.055) 1.21 1.05-1.39  0.001 
Parkinson  0.179 (0.126) 1.19 0.86-1.65  0.155 
Other diseases  0.080 (0.059) 1.08 0.93-1.26  0.177 
Other fractures    0.032 (0.086) 1.03 0.83-1.29  0.710  
Other emotional disorders  -0.020 (0.085) 0.98 0.79-1.22  0.816  
Rheumatoid arthritis -0.024 (0.067) 0.97 0.82-1.16  0.716 
Hypertension  -0.029 (0.049) 0.97 0.86-1.10  0.556 
Stomach ulcer  -0.094 (0.100) 0.91 0.70-1.18  0.350 
Cataracts  -0.112 (0.063) 0.89 0.76-1.05  0.077 
Osteoarthritis  -0.125 (0.061) 0.88 0.75-1.03  0.041 
Cholesterol  -0.259 (0.057) 0.77 0.66-0.89 < 0.001 
B, coefficient regression; SE, Standard error; HR, Hazard ratio; CI, Confidence interval; 
Depression, Euro-D ≥4. 
Unweighted data. Time = Years at risk. Event = Death. Method: Enter. Adjusted for country, 
gender and age. Effect size for HR: small: <1.22, medium: 1.23-2.99, large: ≥3.00. Effect size 
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Table 4  
Cox regression. Multivariate analysis. Risk factors and comorbidities in the eight diseases with the highest risk of mortality 
  Cancer  Dementia  Depression  Fract. (hip/fem.) Stroke  Chronic Lung Diabetes  Heart Attack 
  HR 99,0% CI HR 99,0% CI HR 99,0% CI HR 99,0% CI HR 99,0% CI HR 99,0% CI HR 99,0% CI HR 99,0% CI 
FACTORS† 
Comorbidity  >2 1.90 1.39-2.61* 2.57 1.83-3.62* 1.40 1.18-1.66* 3.58 2.21-5.81* 3.69 2.60-5.24* 4.70 3.36-6.57* 3.85 2.99-4.95* 3.20 2.52-4.06* 
Age cont. 0.98 0.96-0.99* 1.04 1.02-1.06* ………………………. 1.03 1.00-1.06ʺ ………………………. 0.98 0.97-1.00′ ………………….……. 1.01 1.00-1.02′ 
Self-Health fair/poor 6.10 1.64-22.6* ……………………..… 2.40 1.11-5.17ʺ …………….….……… ………………………. 3.81 0.84-17.3′ ………………….……. 7.32 1.64-32.7ʺ 
ADL deficit ≥1 ………………….…… 5.67 2.18-14.7* 1.58 1.25-1.98* 4.39 1.73-11.1* 2.66 1.65-4.27* ………………………. ………………….….… ……………….………. 
Gender male 1.27 0.93-1.72′ ………………….…… ……………….…….. 0.54 0.33-0.89ʺ 1.71 1.21-2.41* ………………….…… ……………………..… 1.44 1.13-1.83* 
Physical ex. no ………………..…….. 2.85 0.97-8.39′ 1.44 1.08-1.92ʺ ……………….………. ………………………. ……….……………… 1.36 0.94-1.96′ ………….……………. 
Loneliness yes 0.68 0.50-0.92ʺ 1.91 1.21-3.02* 1.39 1.16-1.68* ………………..……… ………………………. 0.73 0.53-1.02′ ……………….….…… ……………….………. 
Cognition <14 0.63 0.38-1.03′ 4.32 0.68-27.4′ ………………….…… ………………..……… ………………………. ………………….…… ……………….….…… …………………..…… 
Frailty ≥1 ………………………. ………………….……. 1.37 1.09-1.72* ………………….……. ………………………. ………………………. ………………….….… ……………….………. 
Smoking  yes  ………………………. ………….…….…….. ……………….……… ………………..……… ………………………. 1.51 1.08-2.10ʺ ……………….………. …………………..…… 
COMORBIDITY‡            
Depression  1.63  1.19-2.32* 3.19 2.02-5.03* ………………………. 1.71 1.00-2.93′ 1.73 1.20-2.50* 1.81 1.28-2.56* 1.30 1.00-1.68′ 1.40 1.09-1.80* 
Heart Attack ………………………. ………………………. 1.23 1.03-1.46” ………………………. 1.37 0.96-1.94′ 1.73 1.23-2.41* 1.37 1.06-1.78” ………………………. 
Cholesterol ………………………. ………………………. ………………………. 0.54 0.28-1.05′ ………………………. 1.32 0.92-1.88′ 1.75 1.33-2.29* 1.33 1.02-1.74” 
Other emotional  ………………………. 2.31 1.52-3.51* 1.42 1.11-1.82* ………………………. 1.90 1.19-3.04* ………………………. ………………………. ………………………. 
Chronic Lung ………………………. ………………………. 1.21 0.97-1.49′ ………………………. ………………………. ………………………. 1.29 0.95-1.76′ 1.41 1.05-1.89” 
Hypertension 0.78 0.57-1.06′ ………………………. ………………………. ………………………. 1.47 1.03-2.08” ………………………. 1.49 1.13-1.96* ………………………. 
Diabetes 0.72 0.48-1.07′ ………………………. ………………………. ………………………. ………………………. 1.44 1.01-2.05” ………………………. 1.36 1.04-1.77” 
Other diseases  0.57 0.36-0.89” 0.62 0.38-1.02′ 1.35 1.10-1.65* ………………………. ………………………. ………………………. ………………………. ………………………. 
Dementia 0.56 0.30-1.06′ …………….………… 1.74 1.40-2.16* ………………………. ………………………. ………………………. ………………………. ………………………. 
Parkinson  ………………………. 1.89 1.12-3.21” ………………………. ………………………. ………………………. 0.37 0.11-1.18′ ………………………. ………………………. 
Cancer ………………………. 0.54 0.28-1.01′ 1.45 1.17-1.79* ………………………. ………………………. ………………………. ……………….……… ………………………. 
Osteoarthritis …………………….… ………………………. …………………….… ………………………. 0.53 0.33-0.87” 1.38 0.94-2.03′ ………………………. ………………………. 
Other fractures  ………………………. ………………………. ………………………. 2.79 1.58-4.92* ………………………. ………………………. ………………………. ………………………. 
Unweighted data; HR, Hazard ratio; CI, confidence interval; Depression, EURO-D ≥4; Time = Years at risk. Event = Death by disease. Method: Forward Wald (only significant variables). 
† Adjusted for country; ‡ Adjusted for country, gender and age. ′P < 0.05; ʺP < 0.01; *P < 0.001.  




Supplementary Table 1   
Mortality rates. Factors & diseases in wave 5 of cases of death (wave 6)
Sociodemographic factors & rates† 
 CR Rate 99.0% CI  
Age groups  
 50-64  4.22 4.20 - 4.24 
 65-79 17.51 17.47-17.55 
 ≥ 80 72.04 71.91-72.18 
Gender 
 Female 17.47 17.44-17.51 
 Male 19.53 19.49-19.57 
Marital status 
 Single/Divorced 12.70 12.65-12.75 
 Married 13.52 13.49-13.55 
 Widowed 40.88 40.79-40.98 
Schooling 
 >12 years   9.14  9.11-  9.17 
 12-8 years 16.81 16.78-16.85 
 <8 years 36.25 36.17-36.33 
Income, percent.  
 70-100  9.09  9.06 - 9.12 
 10-60 23.61 23.58-23.65 
Loneliness 
 No 11.01 10.98-11.03 
 Yes 28.83 28.78-28.88 
Cognition 
 >18  3.80  3.78 - 3.82 
 14-18 10.68 10.65-10.71 
 <14 41.11 41.04-41.18 
Self-Health 
 Exc. / V. good  3.32  3.30 - 3.35 
 Good  8.39  8.37 - 8.42 
 Fair / Poor               36.91    36.86-36.97 
ADL deficits 
 No  7.56  7.54 - 7.58 
 ≥ 1 61.47 61.36-61.57 
Frailty 
 No  9.40  9.37 - 9.42 
 ≥ 1 34.05 33.99-34.11 
Ever smoked daily 
 No 19.45 17.90-21.09 
 Yes  21.79 19.96-23.73 
Physical exercise  
 Yes    5.28 5.26-  5.30 
 No  33.21 33.16-33.26 
 
 CR Rate 99.0% CI  
European Regions  
 Continental 12.47 12.44-12.50 
 Nordic 18.71 18.59-18.84 
 Southern 26.58 26.53-26.63 
 Eastern 27.41 27.26-27.57 
Diseases. Frequency of deaths & rates‡ 
  % §  CR Rate 99.0% CI 
Dementia 28.3 166.57 140.93-195.6 
Parkinson  16.3 87.13 62.15-118.5 
Fractures (hip/femur) 13.3 72.14 56.72-90.33 
Stroke 12.3 65.73 55.52-77.22 
Cancer 11.2 61.13 52.50-70.72 
Chronic Lung  9.0 47.68 40.44-55.66 
Heart Attack  8.7  45.30 40.26-50.78 
Depressive symptoms   8.0 41.58 38.36-44.99 
Cataracts  7.6 40.29 34.87-46.29 
Diabetes  6.9 36.18 31.92-40.82 
Rheumatoid arthritis  6.2 31.86 27.26-36.99 
Emotional dis.  5.6 29.19 23.65-35.60 
Stomach ulcer  5.5 28.45 22.00-36.14 
Other fractures  5.2 27.16 21.88-33.28 
Hypertension   4.8 24.84 22.82-26.99 
Other diseases  4.4 22.55 19.58-25.83 
Osteoarthritis  4.3 22.53 19.67-25.68 
Cholesterol  3.9 20.03 17.69-22.60 
None disease  1.2  6.06 4.74-  7.62 
Comorbidity (8 dis.) 
 0-2  3.2 16.44 15.36-17.58 
 > 2 18.4 104.81 92.94-117.7 
Global crude rate  18.39 18.37-18.42 
Standardized rate   18.47 
CR, Crude rate; CI, Confidence Interval; ADL, Activities of daily living; EURO-D, Depression scale. † Weighted data; 
‡ Unweighted data; § Deaths respect to each disease. Crude and standardized mortality rates: deaths *1000 
person-years at risk; Poisson 99.0%CI. Comorbidity (8 dis.) according to Cox regression, table 3 = Cancer, 
Dementia, Depressive symptoms, Fractures (Hip / Femur), Stroke, Chronic Lung, Diabetes and Heart attack. 
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Supplementary Table 2   
Cox regression. Bivariate analysis of diseases for countries in wave 5. Cases of death from wave 6 
  Survivors Deaths Crude values  Adjusted  
   n (%)  n (%) HR (99%CI) P HR (99%CI) P 
Ref. All countries     1.00   1.00 
Continental 
 France 3117 (97.4)  82 (2.6) 0.63 (0.47-0.85) < 0.001 0.58 (0.43-0.78) < 0.001 
 Germany 4204 (97.8)  93 (2.2) 0.45 (0.34-0.60) < 0.001 0.67 (0.51-0.89) < 0.001 
 Luxembourg 1089 (98.4)  18 (1.6) 0.54 (0.29-1.00) 0.011 0.73 (0.40-1.35)  0.186 
 Austria  3045 (97.2)  88 (2.8) 1.48 (1.19-1.96) < 0.001 0.84 (0.63-1.12)  0.116 
 Belgium   4273 (96.6) 149 (3.4) 0.82 (0.66-1.03)  0.025 0.85 (0.68-1.07)  0.078 
 Switzerland 2546 (97.9)  55 (2.1) 0.50 (0.35-0.71) < 0.001 0.99 (0.69-1.42)  0.966 
Nordic 
 Sweden 3512 (97.4)  93 (2.6) 0.75 (0.57-0.99)  0.010 1.08 (0.82-1.43)  0.454 
 Denmark 3295 (96.6) 116 (3.4) 0.91 (0.71-1.16)  0.306 1.52 (1.18-1.97) < 0.001 
Eastern 
 Estonia  4533 (94.0) 287 (6.0) 1.32 (1.12-1.56) < 0.001 1.01 (0.85-1.21)  0.834 
 Slovenia 2366 (96.3)  92 (3.7) 0.97 (0.73-1.27)  0.766 1.12 (0.90-1.41)  0.286 
 Czechia 4340 (94.6) 249 (5.4) 1.53 (1.28-1.83) < 0.001 1.62 (1.35-1.95) < 0.001 
Southern 
 Italy 3596 (96.1) 144 (3.9) 0.99 (0.79-1.23)  0.903 0.82 (0.65-1.03)  0.029 
 Israel  1768 (93.7) 118 (6.3) 1.55 (1.20-1.95) < 0.001 0.96 (0.74-1.24)  0.665 
 Spain  5063 (93.4) 360 (6.6) 1.79 (1.54-2.09) < 0.001 1.12 (0.95-1.32)  0.069 
Regions  
 Continental  18274 (97.4) 485 (2.6) 0.51 (0.45-0.59) < 0.001 0.69 (0.60-0.79) < 0.001 
 Southern 10427 (94.4) 622 (5.6) 1.59 (1.41-1.81) < 0.001 0.99 (0.87-1.13)  0.885 
 Eastern  11239 (94.7) 628 (5.3) 1.41 (1.24-1.60) < 0.001 1.29 (1.13-1.47) < 0.001 
 Nordic 6807 (97.0) 209 (3.0) 0.82 (0.68-0.99)  0.008 1.32 (1.08-1.60) < 0.001 
 
HR, Hazard ratio; CI, Confidence interval  
Unweighted data. Time = Years at risk. Event = Death. Method for Cox regression: Enter. Adjusted for age, 
gender, marital status, self-health, cognition, ADL deficits, comorbidity, loneliness, depression, frailty and 
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Supplementary Table 3  
Frequency of diseases and age of death  
 
 Survivors Deaths Differences Age at death 
 N 46747  (%) 1944  (%) χ2 (P) V Mean (SD) Median  IQR  
 Dementia 644  (71.7) 254  (28.3) < 0.001 0.17 85.7  (7.1) 86.2 9.46 
 Depressive symptoms 12213  (92.0) 1066  (8.0) < 0.001 0.12 80.9  (9.8) 82.0 13.50 
 Stroke  1792 (87.7) 252  (12.3) < 0.001 0.09 80.7  (8.3) 81.1 11.56 
 Cancer 2439  (88.8) 308  (11.2) < 0.001 0.09 76.1  (9.8) 77.0 14.02 
 Heart attack 5310  (91.3) 506  (8.7) < 0.001 0.09 80.7  (9.1) 82.1 12.50 
 Fractures (hip/femur) 836  (86.7) 128  (13.3) < 0.001 0.07 84.2  (8.5) 85.3 11.44 
 Chronic lung 2734  (91.0) 272  (9.0) < 0.001 0.07 78.1  (10.5) 79.6 15.08 
 Diabetes 6049  (93.1) 449  (6.9) < 0.001 0.06 79.2  (9.2) 80.3 13.13 
 Parkinson 354  (83.7) 69  (16.3) < 0.001 0.06 83.2  (6.7) 83.8 6.96 
 Cataracts 4108  (92.4) 339  (7.6) < 0.001 0.06 83.0  (8.0) 83.3 10.25 
 Rheumatoid arthritis 4424  (93.8) 293  (6.2) < 0.001 0.04 80.9  (9.7) 82.4 12.58 
 Hypertension 18976  (95.2) 961  (4.8) < 0.001 0.04 79.3  (9.4) 80.3 12.84 
 Other emotional dis.  2757  (94.4) 165  (5.6) < 0.001 0.02 79.5  (10.0) 80.3 14.96 
 Stomach ulcer  1933  (94.5) 112  (5.5) < 0.001 0.02 78.1  (10.3) 79.8 15.90 
 Other fractures  2865  (94.8) 156  (5.2) < 0.001 0.02 78.2  (10.3) 79.7 13.06 
 Other diseases 7827  (95.6) 357  (4.4) 0.047 0.01 79.3  (10.1) 80.7 15.21 
 Osteoarthritis 8535  (95.7) 381  (4.3) 0.107 0.01 80.6  (9.7) 82.0 13.00 
 Cholesterol  11194  (96.1) 452  (3.9) 0.565 0.00 78.5  (9.3) 79.8 13.87 
 None diseases  10198  (98.8) 124  (1.2) < 0.001 0.07 76.4  (11.1) 77.3 17.99 
 All cases     79.4 (10.0) 80.7 14.59 
Unweighted data. χ2 = Chi-Square test; SD, Standard deviation; IQR, Interquartile range; V, Effect size for Cramer’s 
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Supplementary Table 4 




 EUROPEAN UNION (28 countries), EUROSTAT SHARE (15 countries), EUROSTAT † SHARE STUDY ‡,§ 
Age Population Deaths CR Population Deaths CR STR Years at risk Deaths CR STR 
50-64 165,170,518 630,409 3.81 63,351,395 335,258 5.29  90,145,436 380,565 4.22  
65-79 67,965,760 1,452,347 21.36 43,816,674 835,550 19.06  68,656,074 1,202,298 17.51  
≥ 80 26,054,664 2,611,167 100.21 17,640,816 1,691,557 95.88  25,020,670 1,802,710 72.04  
Total 259,190,942 4,693,923 18.10 124,808,885 2,862,365 22.93 18.00 184,000,000 3,385,573 18.39 18.47 
CR, Crude rate *1000 hab.; STR, Standardized rate*1000 hab.  
†The reference for the standardized rate of the 15 SHARE countries is the data from the 28 European Countries, Eurostat (2014) 
‡The reference for the standardized rate of the SHARE study is the data from the 15 SHARE countries, Eurostat (2014) 
§ Weighted data. 
